Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity

Journal of Hypertension

Volumn 14, Issue 2, 1996, Pages 199-207

  Hopkins, Paul N ^a,f   Lifton, Richard P ^b,e   Hollenberg, Norman K ^b   Jeunemaitre, Xavier ^c   Hallouin, Marie Charlotte ^c   Skuppin, Jan ^a   Williams, Christopher S ^d   Dluhy, Robert G ^b   Lalouel, Jean Marc ^a   Williams, Roger R ^a   Williams, Gordon H ^b  

^a UNIVERSITY OF UTAH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c INSERM   (France)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NONE   (United States)

Author keywords

Angiotensinogen; Genetics; Hemodynamics; Polymorphism; Renal circulation; Renin angiotensin system

Indexed keywords

ANGIOTENSIN;

ADULT; ARTERY RESISTANCE; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; ESSENTIAL HYPERTENSION; GENE; GENETIC LINKAGE; GENOTYPE; HUMAN; KIDNEY CIRCULATION; KIDNEY PLASMA FLOW; MULTIVARIATE ANALYSIS; OBESITY; PRIORITY JOURNAL; SODIUM BALANCE;

EID: 0029937834     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199602000-00008     Document Type: Article

References (47)

1. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al.: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992, 71:169-180.
2. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, et al.: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994, 330:1629-1633.
3. Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, et al.: Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995, 96:687-692.
4. Jeunemaitre X, Charru A, Chatellier G, Dumont C, Sassano P, Soubrier F, et al.: M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens 1993, 11 (suppl 5):S80-S81.
5. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, et al.: Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994, 93:1285-1287.
6. Bennett CL, Schrader AP, Morris BJ: Cross-sectional analysis of Met235→Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun 1993, 197:833-839.
7. Hegele RA, Brunt JH, Connelly PW: A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 1994, 90:2207-2212.
8. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, et al.: A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet 1993, 4:59-61.
9. Douglas JG, Brown GP: Effect of prolonged low dose infusion of angiotensin II and aldosterone on rat smooth muscle and adrenal angiotensin II receptors. Endocrinology 1982, 111:988-992.
10. Iwai N, Inagami T: Regulation of the expression of the rat angiotensin II receptor mRNA. Biochem Biophys Res Commun 1992, 182:1094-1099.
11. Llorens-Cortes C, Greenberg B, Huang H, Corvol P: Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 1994, 24:538-548.
12. Platia MP, Catt KJ, Hodgen GD, Aguilera G: Regulation of primate angiotensin II receptors during altered sodium intake. Hypertension 1986, 8:1121-1126.
13. Hollenberg NK, Williams GH: Abnormal renal function, sodium-volume homeostasis, and renin system behavior in normal-renin essential hypertension. In Hypertension: Pathophysiology, Diagnosis, and Management Edited by Laragh JH, Brenner BM. New York: Raven Press; 1990:1349-1370.
14. Williams RR, Hunt SC, Hopkins PN, Stults BM, Wu LL, Hasstedt SJ, et al.: Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA 1988, 259:3579-3586.
15. Shoback DM, Williams GH, Moore TJ, Dluhy RG, Podolsky S, Hollenberg NK: Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest 1983, 72:2115-2124.
16. Schnurr E, Lahme W, Kuppers H: Measurement of renal clearance of inulin and PAH in the steady state without urine collection. Clin Nephrol 1980, 13:26-29.
17. Underwood RH, Williams GH: The simultaneous measurement of aldosterane, cortisol, and corticosterone in human peripheral plasma by displacement analysis. J Lab Clin Med 1972, 79:848-862.
18. Emanuel R, Cain JP, Williams GH: Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. J Lab Clin Med 1973, 81:632-640.
19. Plouin PF, Chatellier G, Guyenne TT, Vincent N, Corvol P: Recent advances in the clinical investigation of the renin system: normal values and conditions of validity. Presse Med 1989, 18:917-921.
20. Du Bois D, Du Bois EF: A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916, 17:863-871.
21. Hollenberg NK, Solomon HS, Adams DF, Abrams HL, Merrill JP: Renal vascular response to angiotensin and norepinephrine i normal man: effect of salt intake. Circ Res 1972, 31:750-757.
22. Burger BM, Hopkins T, Tulloch A, Hollenberg NK: The role of angiotensin in the canine renal vascular response to barbiturate anesthesia. Circ Res 1976, 38:196-202.
23. Gunther S, Gimbrone Jr MA, Alexander RW: Regulation by angiotensin II of its receptors in resistance blood vessels. Nature 1980, 287:230-232.
24. Luparini RL, Ferri C, Santucci A, Balsano F: Atrial natriuretic peptide in non-modulating essential hypertension. Hypertension 1993, 21:803-809.
25. Williams GH, Dluhy RG, Lifton RP, Moore TJ, Gleason R, Williams R, et al.: Non-modulation as an intermediate phenotype in essential hypertension. Hypertension 1992, 20:788-796.
26. Hollenberg HK, Meggs LG, Williams GH, Kate J, Garnic JD, Harrington DP: Sodium intake and renal responses to captopril in normal man and in essential hypertension. Kidney Int 1981, 20:240-245.
27. Shoback DM, Williams GH, Hollenberg HK, Davies RO, Moore TJ, Dluhy RG: Endogenous angiotensin II as a determinant of sodium modulated changes in tissue responsiveness to angiotensin II in normal man. J Clin Endocrinol Metab 1983, 57:764-770.
28. Redgrave J, Rabinowe S, Hollenberg NK, Williams GH: Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives. J Clin Invest 1985, 75:1285-1290.
29. Dluhy RG, Smith K, Taylor T, Hollenberg NK, Williams GH: Prolonged converting enzyme inhibition in non-modulating hypertension. Hypertension 1989, 13:371-377.
30. Hall WH, Shappell SD, Doherty JE: Effect of cholestyramine on digoxin absorption and excretion in man. Am J Cardiol 1977, 39:213-216.
31. Schuster VL, Kokko JP, Jacobson HR: Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules. J Clin Invest 1984, 73:507-515.
32. Dzau VJ: Renal and circulatory mechanisms in congestive heart failure. Kidney Int 1987, 31:1402-1415.
33. Cogan MG: Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 1990, 15:451-458.
34. Deschepper CF, Mellon SH, Cumin F, Baxter JD, Ganong WF: Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat Proc Natl Acad Sci USA 1986, 83:7552-7556.
35. Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, Dzau VJ: In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. J Clin Invest 1990, 85:417-423.
36. Admiraal PJJ, Derkx FHM, Danser AHJ, Pieterman H, Schalekamp MADH: Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 1990, 15:44-55.
37. Schunkert H, Ingelfinger JR, Hirsch AT, Tang S-S, Litwin SE, Talsness CE, et al.: Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure. J Clin Invest 1992, 90:1523-1529.
38. Schunkert H, Ingelfinger JR, Jacob H, Jackson B, Bouyounes B, Dzau VJ: Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol 1992, 263:E863-E869.
39. Eggena P, Barrett JD: Regulation and functional consequences of angiotensinogen gene expression. J Hypertens 1992, 10:1307-1311.
40. Frederich RCJ, Kahn BB, Peach MJ, Flier JS: Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992, 19:339-344.
41. Tamura K, Umemura S, Iwamoto T, Yamaguchi S, Kobayashi S, Takeda K, et al.: Molecular mechanism of adipogenic activation of the angiotensinogen gene. Hypertension 1994, 23:364-368.
42. de Leeuw PW, Birkenhger WH: Renal hemodynamic patterns and the autonomic control of renal renin secretion in essential hypertension. In: Hypertension: Pathophysiology, Diagnosis, and Management. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1990:1371-1382.
43. Scherrer U, Randin D, Tappy L, Vollenweider P, J quier E, Nicod P: Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994, 89:2634-2640.
44. Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Landsberg L: Relation of obesity and diet to sympathetic nervous system activity. Hypertension 1991, 17:669-677.
45. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL: Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991, 87:2246-2252.
46. Dluhy RG, Hopkins P, Hollenberg NK, Williams GH, Williams RR: Heritable abnormalities of the renin-angiotensin-aldosterone system in essential hypertension. J Cardiovasc Pharmacol 1988, 12 (suppl 3):S149-S154.
47. Lifton RP, Hopkins PN, Williams RR, Hollenberg NK, Williams GH, Dluhy RG: Evidence for heritability of non-modulating essential hypertension. Hypertension 1989, 13:884-889.